GuangYuYuan Chinese Herbal Medicine Co., Ltd. (SHA:600771)
China
· Delayed Price · Currency is CNY 16.90
-0.03 (-0.18%)
Apr 29, 2026, 3:00 PM CST
SHA:600771 Revenue
GuangYuYuan Chinese Herbal Medicine had revenue of 488.22M CNY in the quarter ending March 31, 2026, with 17.04% growth. This brings the company's revenue in the last twelve months to 1.44B, up 11.21% year-over-year. In the year 2025, GuangYuYuan Chinese Herbal Medicine had annual revenue of 1.37B with 12.11% growth.
Revenue (ttm)
1.44B
Revenue Growth
+11.21%
P/S Ratio
5.75
Revenue / Employee
830.19K
Employees
1,735
Market Cap
8.29B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.37B | 147.88M | 12.11% |
| Dec 31, 2024 | 1.22B | -62.59M | -4.87% |
| Dec 31, 2023 | 1.28B | 153.30M | 13.56% |
| Dec 31, 2022 | 1.13B | 276.50M | 32.37% |
| Dec 31, 2021 | 854.22M | -255.21M | -23.00% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nanjing Pharmaceutical Group Company | 54.96B |
| Shanghai InnoStar Bio-tech | 811.33M |
| Chongqing Lummy Pharmaceutical | 759.50M |
| Zhejiang Jolly Pharmaceutical Co.,LTD | 3.11B |
| Hangzhou Bio-Sincerity Pharma-Tech | 590.33M |
| Zhejiang Int'l Group | 33.68B |
| Yifan Pharmaceutical | 5.06B |
| CSPC Hunan Jingfeng Pharmaceutical | 393.19M |